Logo image of PRLB

PROTO LABS INC (PRLB) Stock Fundamental Analysis

NYSE:PRLB - New York Stock Exchange, Inc. - US7437131094 - Common Stock - Currency: USD

40.54  -0.63 (-1.53%)

After market: 40.54 0 (0%)

Fundamental Rating

5

PRLB gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 128 industry peers in the Machinery industry. PRLB has a great financial health rating, but its profitability evaluates not so good. PRLB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

PRLB had positive earnings in the past year.
In the past year PRLB had a positive cash flow from operations.
Of the past 5 years PRLB 4 years were profitable.
Each year in the past 5 years PRLB had a positive operating cash flow.
PRLB Yearly Net Income VS EBIT VS OCF VS FCFPRLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

PRLB has a worse Return On Assets (2.02%) than 60.16% of its industry peers.
With a Return On Equity value of 2.27%, PRLB is not doing good in the industry: 63.28% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 2.21%, PRLB is doing worse than 67.97% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PRLB is significantly below the industry average of 10.71%.
Industry RankSector Rank
ROA 2.02%
ROE 2.27%
ROIC 2.21%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
PRLB Yearly ROA, ROE, ROICPRLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

PRLB has a Profit Margin of 2.99%. This is comparable to the rest of the industry: PRLB outperforms 42.19% of its industry peers.
In the last couple of years the Profit Margin of PRLB has declined.
PRLB has a Operating Margin of 4.64%. This is in the lower half of the industry: PRLB underperforms 63.28% of its industry peers.
PRLB's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 44.36%, PRLB belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
PRLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.64%
PM (TTM) 2.99%
GM 44.36%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
PRLB Yearly Profit, Operating, Gross MarginsPRLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

PRLB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, PRLB has less shares outstanding
Compared to 5 years ago, PRLB has less shares outstanding
The debt/assets ratio for PRLB has been reduced compared to a year ago.
PRLB Yearly Shares OutstandingPRLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRLB Yearly Total Debt VS Total AssetsPRLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

PRLB has an Altman-Z score of 8.61. This indicates that PRLB is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.61, PRLB belongs to the top of the industry, outperforming 91.41% of the companies in the same industry.
PRLB has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.01, PRLB belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
PRLB has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of PRLB (0.00) is better than 85.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 8.61
ROIC/WACC0.22
WACC9.91%
PRLB Yearly LT Debt VS Equity VS FCFPRLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 3.13 indicates that PRLB has no problem at all paying its short term obligations.
PRLB has a better Current ratio (3.13) than 78.13% of its industry peers.
A Quick Ratio of 2.92 indicates that PRLB has no problem at all paying its short term obligations.
PRLB has a better Quick ratio (2.92) than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 2.92
PRLB Yearly Current Assets VS Current LiabilitesPRLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

PRLB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.24%.
The earnings per share for PRLB have been decreasing by -10.19% on average. This is quite bad
The Revenue has decreased by -1.33% in the past year.
Measured over the past years, PRLB shows a small growth in Revenue. The Revenue has been growing by 1.78% on average per year.
EPS 1Y (TTM)-8.24%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%-17.5%
Revenue 1Y (TTM)-1.33%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%-1.32%

3.2 Future

The Earnings Per Share is expected to decrease by -0.91% on average over the next years.
The Revenue is expected to grow by 3.54% on average over the next years.
EPS Next Y-14.33%
EPS Next 2Y-0.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.47%
Revenue Next 2Y3.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PRLB Yearly Revenue VS EstimatesPRLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
PRLB Yearly EPS VS EstimatesPRLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 25.99 indicates a quite expensive valuation of PRLB.
PRLB's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.29, PRLB is valued at the same level.
PRLB is valuated quite expensively with a Price/Forward Earnings ratio of 25.33.
PRLB's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. PRLB is more expensive than 61.72% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of PRLB to the average of the S&P500 Index (21.74), we can say PRLB is valued inline with the index average.
Industry RankSector Rank
PE 25.99
Fwd PE 25.33
PRLB Price Earnings VS Forward Price EarningsPRLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as PRLB.
PRLB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PRLB is cheaper than 81.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.38
EV/EBITDA 14.57
PRLB Per share dataPRLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.91%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PRLB!.
Industry RankSector Rank
Dividend Yield N/A

PROTO LABS INC

NYSE:PRLB (7/7/2025, 8:04:00 PM)

After market: 40.54 0 (0%)

40.54

-0.63 (-1.53%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)08-01 2025-08-01/bmo
Inst Owners93.25%
Inst Owner Change0%
Ins Owners1.05%
Ins Owner Change3.43%
Market Cap963.64M
Analysts76.36
Price Target45.9 (13.22%)
Short Float %3.31%
Short Ratio3.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.65%
Min EPS beat(2)10.87%
Max EPS beat(2)16.42%
EPS beat(4)4
Avg EPS beat(4)19.58%
Min EPS beat(4)7.67%
Max EPS beat(4)43.37%
EPS beat(8)8
Avg EPS beat(8)28.54%
EPS beat(12)11
Avg EPS beat(12)24.23%
EPS beat(16)13
Avg EPS beat(16)20.86%
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-0.63%
Max Revenue beat(2)0.02%
Revenue beat(4)2
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-2.44%
Max Revenue beat(4)1.46%
Revenue beat(8)4
Avg Revenue beat(8)0.08%
Revenue beat(12)6
Avg Revenue beat(12)0.05%
Revenue beat(16)7
Avg Revenue beat(16)-0.07%
PT rev (1m)0%
PT rev (3m)1.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.91%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.53%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)0.66%
Valuation
Industry RankSector Rank
PE 25.99
Fwd PE 25.33
P/S 1.93
P/FCF 14.38
P/OCF 12.87
P/B 1.47
P/tB 2.66
EV/EBITDA 14.57
EPS(TTM)1.56
EY3.85%
EPS(NY)1.6
Fwd EY3.95%
FCF(TTM)2.82
FCFY6.96%
OCF(TTM)3.15
OCFY7.77%
SpS21
BVpS27.63
TBVpS15.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.02%
ROE 2.27%
ROCE 3.43%
ROIC 2.21%
ROICexc 2.58%
ROICexgc 5.26%
OM 4.64%
PM (TTM) 2.99%
GM 44.36%
FCFM 13.43%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
ROICexc(3y)2.8%
ROICexc(5y)3.78%
ROICexgc(3y)5.45%
ROICexgc(5y)6.71%
ROCE(3y)3.77%
ROCE(5y)4.91%
ROICexcg growth 3Y-8.13%
ROICexcg growth 5Y-18.97%
ROICexc growth 3Y-4.98%
ROICexc growth 5Y-24.03%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 22.16%
Cap/Sales 1.57%
Interest Coverage 250
Cash Conversion 127.85%
Profit Quality 449.12%
Current Ratio 3.13
Quick Ratio 2.92
Altman-Z 8.61
F-Score6
WACC9.91%
ROIC/WACC0.22
Cap/Depr(3y)51.87%
Cap/Depr(5y)76.84%
Cap/Sales(3y)3.95%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.24%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%-17.5%
EPS Next Y-14.33%
EPS Next 2Y-0.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.33%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%-1.32%
Revenue Next Year2.47%
Revenue Next 2Y3.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-26.12%
EBIT growth 3Y-14.15%
EBIT growth 5Y-20.42%
EBIT Next Year53.89%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.28%
FCF growth 3Y48.42%
FCF growth 5Y4.96%
OCF growth 1Y11.91%
OCF growth 3Y12.13%
OCF growth 5Y-7.69%